Microarray analysis of Mycobacterium tuberculosis-infected monocytes reveals IL26 as a new candidate gene for

José M Guerra-Laso1, Sara Raposo-García, Silvia García-García

  • 1Servicios de Medicina Interna, Complejo Asistencial Universitario de León (CAULE), León, Spain.

Immunology
|August 27, 2014
PubMed

Insights

Interleukin-26 (IL-26) is down-regulated in tuberculosis patients, reducing the body's ability to fight Mycobacterium tuberculosis. Lower IL-26 levels may indicate increased tuberculosis susceptibility.

Area of Science:

  • Immunology
  • Genetics
  • Infectious Diseases

Background:

  • Monocyte/macrophage activity is crucial in Mycobacterium tuberculosis infection.
  • Elderly individuals are a known tuberculosis susceptibility group.

Purpose of the Study:

  • Identify candidate genes associated with tuberculosis susceptibility.
  • Investigate the role of interleukin-26 (IL-26) in tuberculosis.

Main Methods:

  • Infection of monocytes from healthy elderly individuals and tuberculosis patients with M. tuberculosis.
  • Microarray analysis to detect differentially expressed transcripts.
  • Quantitative PCR for gene expression validation.
  • Measurement of IL-26 serum concentrations and its effect on M. tuberculosis killing capability in whole blood.

Main Results:

  • 78 differentially expressed transcripts were identified, with IL-26 being significantly down-regulated in infected monocytes from tuberculosis patients.
  • IL-26 production decreased upon M. tuberculosis infection.
  • Lower IL-26 serum concentrations were observed in tuberculosis patients.
  • IL-26 inhibited pathogen-killing capability in whole blood, potentially mediated by lymphocytes.

Conclusions:

  • IL-26 may play a role in modulating the anti-mycobacterial response.
  • Down-regulation of IL-26 is associated with tuberculosis.
  • IL26 is proposed as a candidate gene for tuberculosis susceptibility.